EA202192635A1 - Фармацевтическая композиция, содержащая бензоазепиновое соединение - Google Patents
Фармацевтическая композиция, содержащая бензоазепиновое соединениеInfo
- Publication number
- EA202192635A1 EA202192635A1 EA202192635A EA202192635A EA202192635A1 EA 202192635 A1 EA202192635 A1 EA 202192635A1 EA 202192635 A EA202192635 A EA 202192635A EA 202192635 A EA202192635 A EA 202192635A EA 202192635 A1 EA202192635 A1 EA 202192635A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- composition containing
- benzoazepine compound
- agent
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Представлено средство для уменьшения побочных эффектов толваптана. В частности, средство представляет собой фармацевтическую композицию, включающую соединение, представленное формулой (1)или его соль металла, при этом фармацевтическую композицию используют таким образом, что соединение, представленное формулой (1), или его соль металла вводят трансваскулярно в количестве 4-20 мг в течение периода времени 10 мин или больше.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019064357 | 2019-03-28 | ||
PCT/JP2020/013935 WO2020196816A1 (en) | 2019-03-28 | 2020-03-27 | Benzoazepine compound-containing pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202192635A1 true EA202192635A1 (ru) | 2021-12-10 |
Family
ID=70289832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202192635A EA202192635A1 (ru) | 2019-03-28 | 2020-03-27 | Фармацевтическая композиция, содержащая бензоазепиновое соединение |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220152064A1 (ru) |
EP (1) | EP3946362A1 (ru) |
JP (2) | JP7130879B2 (ru) |
KR (1) | KR20210144811A (ru) |
CN (1) | CN113631169A (ru) |
EA (1) | EA202192635A1 (ru) |
WO (1) | WO2020196816A1 (ru) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1968990T3 (pl) * | 2005-12-27 | 2015-06-30 | Otsuka Pharma Co Ltd | Rozpuszczalny w wodzie związek benzoazepinowy i jego kompozycja farmaceutyczna |
JP5590780B2 (ja) * | 2007-06-26 | 2014-09-17 | 大塚製薬株式会社 | 医薬 |
TW201605488A (zh) | 2013-10-15 | 2016-02-16 | 大塚製藥股份有限公司 | 用以預防及/或治療多囊腎病之藥物 |
-
2020
- 2020-03-27 JP JP2021540578A patent/JP7130879B2/ja active Active
- 2020-03-27 WO PCT/JP2020/013935 patent/WO2020196816A1/en unknown
- 2020-03-27 EA EA202192635A patent/EA202192635A1/ru unknown
- 2020-03-27 CN CN202080023549.6A patent/CN113631169A/zh active Pending
- 2020-03-27 EP EP20719509.0A patent/EP3946362A1/en active Pending
- 2020-03-27 KR KR1020217034478A patent/KR20210144811A/ko active Search and Examination
- 2020-03-27 US US17/439,061 patent/US20220152064A1/en active Pending
-
2022
- 2022-08-15 JP JP2022129393A patent/JP2022163190A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7130879B2 (ja) | 2022-09-05 |
JP2022519343A (ja) | 2022-03-23 |
KR20210144811A (ko) | 2021-11-30 |
US20220152064A1 (en) | 2022-05-19 |
WO2020196816A1 (en) | 2020-10-01 |
CN113631169A (zh) | 2021-11-09 |
EP3946362A1 (en) | 2022-02-09 |
JP2022163190A (ja) | 2022-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020106647A3 (en) | Combination therapy including a krasg12c inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | |
MX2020011196A (es) | Una sal sodica de n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamo il)-1-isopropil-1h-pirazol-3-sulfonamida. | |
MA51204B1 (fr) | Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique | |
TW200833370A (en) | Pharmaceutical composition containing low substituted hydroxypropylcellulose | |
MX2021010106A (es) | Inhibidores de la via de respuesta al estres integrada. | |
TW200639159A (en) | Treatment of pain | |
MX2022001784A (es) | Piperidinil-metil-purinaminas como inhibidores de nsd2 y antineoplásicos. | |
MY145569A (en) | Benzamide compounds useful as histone deacetylase inhibitors | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
CR20220251A (es) | Nuevos derivados de metilquinazolinona | |
TW200517106A (en) | Sustained release pharmaceutical compositions | |
WO2012168885A9 (en) | Bisacodyl and its analogues as drugs for use in the treatment of cancer | |
PH12021550713A1 (en) | Medicament for the treatment of chronic cough | |
MX2021014680A (es) | Derivado de benzotriazol. | |
AU2020288567A8 (en) | Pyrrolopyrimidine compound and use thereof | |
PH12021550554A1 (en) | N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors | |
MX2020010697A (es) | Kit, composicion y terapia de combinacion para el sindrome del cromosoma x fragil. | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
PH12020551341A1 (en) | 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof | |
TW200719903A (en) | Compositions for the treatment of neoplasms | |
CR20190545A (es) | Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias | |
MX2022008487A (es) | Degradadores de smarca2-vhl. | |
PH12020551117A1 (en) | Compositions for preventing or treating uveitis | |
MX2022006104A (es) | Composicion farmaceutica oral que comprende compuesto de carbamato y metodo de preparacion para la misma. | |
EA202192635A1 (ru) | Фармацевтическая композиция, содержащая бензоазепиновое соединение |